Ryder(US:R) Newsfile·2025-11-10 12:25Core Insights - Delivra Health Brands reported a 1% increase in net revenue for Q1 2026, reaching $3,207 thousand, driven by an 8% growth in Dream Water® sales and a 9% increase in LivRelief™ Non-Infused sales, despite a significant decline in licensed LivRelief™ Infused sales [5][6][10] - The company experienced a gross profit of $1,501 thousand with a gross profit margin of 47%, down from 51% in the same period last year, attributed to higher sales fees and changes in customer and product mix [5][6] - Adjusted EBITDA improved to $56 thousand from $16 thousand year-over-year, reflecting a $40 thousand increase due to higher sales volume and reduced sales and marketing expenses [10][8] Financial Performance - Net revenue for Q1 2026 was $3,207 thousand, compared to $3,163 thousand in Q1 2025, marking a $44 thousand increase [5][6] - Gross profit decreased to $1,501 thousand from $1,598 thousand, with a gross profit margin of 47% compared to 51% in the previous year [5][6] - Total expenses excluding non-cash items were $1,447 thousand, down 10% from $1,607 thousand in Q1 2025, primarily due to reduced sales and marketing expenses [10][7] Sales Growth - Dream Water® sales grew by 8% in the U.S. and Canada, while e-commerce sales for Dream Water® surged by 74% compared to the same quarter last year [5][6] - LivRelief™ experienced a 9% growth in sales, with e-commerce sales increasing by 16% [5][6] - The company anticipates a return to growth for the licensed LivRelief™ Infused segment in the second half of fiscal 2026 following a transition to a new distribution partner [2][5] Management Strategy - The management emphasized the importance of innovation, marketing, and channel diversification in driving recurring consumer demand [2] - Plans for new product launches with strategic customers are set for the second half of fiscal 2026 to enhance market coverage and customer base [2]